Levetiracetam Prophylaxis in Brain Tumor Resection Pilot
NCT ID: NCT05897658
Last Updated: 2024-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE3
70 participants
INTERVENTIONAL
2025-03-31
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
NCT00415376
Levetiracetam for Seizure Prevention After Brain Tumor Surgery
NCT07239115
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
NCT00629889
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
NCT06866691
Prevention of Post-traumatic Seizures With Levetiracetam
NCT00566046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Seizure Prophylaxis (Levetiracetam)
Levetiracetam 1 g taken orally twice a day for 7 days
Levetiracetam
Tablets
Placebo
Placebo taken orally twice a day for 7 days
Placebo
Tablets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levetiracetam
Tablets
Placebo
Tablets
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing craniotomy for a brain tumor
* Intra-axial tumor location
* Supratentorial tumor location
Exclusion Criteria
* Currently taking an antiepileptic medication
* Unable to take levetiracetam (e.g. allergy, inability to swallow)
* Inability to obtain consent from participant or substitute decision maker prior to surgery
* Renal impairment with eGFR less than 50
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Hamilton Health Sciences Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14147
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.